Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial

IMPORTANCE: Clinically used breast cancer markers, such as tumor size, tumor grade, progesterone receptor (PR) status, and Ki-67 status, are known to be associated with short-term survival, but the association of these markers with long-term (25-year) survival is unclear. OBJECTIVE: To assess the as...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:JAMA Netw Open
المؤلفون الرئيسيون: Dar, Huma, Johansson, Annelie, Nordenskjöld, Anna, Iftimi, Adina, Yau, Christina, Perez-Tenorio, Gizeh, Benz, Christopher, Nordenskjöld, Bo, Stål, Olle, Esserman, Laura J., Fornander, Tommy, Lindström, Linda S.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Medical Association 2021
الموضوعات:
Original Investigation
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246315/
https://ncbi.nlm.nih.gov/pubmed/34190995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.14904
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة